InsiderTrades.com logo

ALNY Insider Trading

Insider Ownership Percentage: 1.50%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $97,190,879.32

Alnylam Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Alnylam Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Alnylam Pharmaceuticals Share Price & Price History

Current Price: $465.34
Price Change: ▼ Price Decrease of -7.95 (-1.68%)
As of 12/4/2025 05:00 PM ET

This chart shows the closing price history over time for ALNY up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Alnylam Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
11/17/2025Kevin Joseph FitzgeraldEVPSell12,128$452.18$5,484,039.0421,264View SEC Filing Icon  
11/13/2025Yvonne GreenstreetCEOSell10,000$451.27$4,512,700.0065,409View SEC Filing Icon  
11/12/2025Yvonne GreenstreetCEOSell15,650$453.69$7,100,248.5065,409View SEC Filing Icon  
10/3/2025Pushkal GargEVPSell3,022$451.48$1,364,372.5620,221View SEC Filing Icon  
10/2/2025Jeffrey V. PoultonEVPSell3,821$452.05$1,727,283.0554,052View SEC Filing Icon  
10/2/2025Kevin Joseph FitzgeraldEVPSell2,441$452.05$1,103,454.0525,231View SEC Filing Icon  
10/2/2025Pushkal GargEVPSell2,937$452.05$1,327,670.8523,243View SEC Filing Icon  
10/2/2025Tolga TangulerEVPSell1,405$452.05$635,130.2527,438View SEC Filing Icon  
10/2/2025Yvonne GreenstreetCEOSell8,924$452.05$4,034,094.2065,409View SEC Filing Icon  
9/9/2025Colleen F. ReitanDirectorSell18,000$467.60$8,416,800.00775View SEC Filing Icon  
8/19/2025Pushkal GargEVPSell1,455$458.41$666,986.5520,221View SEC Filing Icon  
8/18/2025Jeffrey V. PoultonEVPSell2,274$453.27$1,030,735.9850,121View SEC Filing Icon  
8/18/2025Kevin Joseph FitzgeraldEVPSell1,396$453.27$632,764.9222,719View SEC Filing Icon  
8/18/2025Michael W. BonneyDirectorSell11,250$450.00$5,062,500.0016,804View SEC Filing Icon  
8/18/2025Pushkal GargEVPSell1,396$453.27$632,764.9221,676View SEC Filing Icon  
8/18/2025Tolga TangulerEVPSell1,396$453.27$632,764.9229,466View SEC Filing Icon  
8/18/2025Yvonne GreenstreetCEOSell6,979$453.27$3,163,371.3356,221View SEC Filing Icon  
8/14/2025Dennis A. AusielloDirectorSell31,448$436.58$13,729,567.84911View SEC Filing Icon  
6/2/2025Yvonne GreenstreetCEOSell19,297$306.00$5,904,882.0048,948View SEC Filing Icon  
5/30/2025Yvonne GreenstreetCEOSell31,640$304.39$9,630,899.6048,948View SEC Filing Icon  
2/18/2025Kevin Joseph FitzgeraldEVPSell1,440$251.56$362,246.4012,881View SEC Filing Icon  
2/18/2025Pushkal GargCMOSell1,548$251.67$389,585.1611,989View SEC Filing Icon  
2/14/2025Jeffrey V. PoultonCFOSell967$255.17$246,749.3932,786View SEC Filing Icon  
2/14/2025Kevin Joseph FitzgeraldEVPSell663$255.21$169,204.2314,321View SEC Filing Icon  
2/14/2025Pushkal GargCMOSell1,561$255.17$398,320.3713,537View SEC Filing Icon  
2/14/2025Yvonne GreenstreetCEOSell1,213$255.17$309,521.2181,526View SEC Filing Icon  
1/27/2025Pushkal GargCMOSell52,592$285.00$14,988,720.0011,989View SEC Filing Icon  
1/23/2025Phillip A. SharpDirectorSell11,250$275.00$3,093,750.00View SEC Filing Icon  
12/12/2024Pushkal GargCMOSell1,752$251.00$439,752.0015,705View SEC Filing Icon  
11/26/2024Pushkal GargCMOSell1,682$250.98$422,148.3617,457View SEC Filing Icon  
11/26/2024Tolga TangulerEVPSell1,469$250.98$368,689.6213,191View SEC Filing Icon  
11/26/2024Yvonne GreenstreetCEOSell5,219$250.98$1,309,864.6278,880View SEC Filing Icon  
8/20/2024Yvonne GreenstreetCEOSell15,000$280.00$4,200,000.0073,441View SEC Filing Icon  
8/6/2024Dennis A. AusielloDirectorSell20,250$262.00$5,305,500.00136View SEC Filing Icon  
8/1/2024Yvonne GreenstreetCEOSell15,148$270.00$4,089,960.0073,441View SEC Filing Icon  
7/11/2024Yvonne GreenstreetCEOSell7,093$261.00$1,851,273.0073,441View SEC Filing Icon  
6/25/2024Jeffrey V. PoultonCFOSell1,605$231.00$370,755.0028,892View SEC Filing Icon  
6/25/2024Kevin Joseph FitzgeraldEVPSell1,198$230.99$276,726.0214,181View SEC Filing Icon  
6/25/2024Pushkal GargCMOSell2,103$230.99$485,771.9715,609View SEC Filing Icon  
6/25/2024Yvonne GreenstreetCEOSell8,301$230.99$1,917,447.9980,534View SEC Filing Icon  
6/24/2024David E. I. PyottDirectorSell32,450$220.69$7,161,390.50136View SEC Filing Icon  
5/29/2024Amy W. SchulmanDirectorSell21,700$148.60$3,224,620.008,436View SEC Filing Icon  
12/27/2023Michael W. BonneyDirectorSell30,000$195.00$5,850,000.0016,029View SEC Filing Icon  
8/7/2023Pushkal GargCMOSell4,166$183.89$766,085.744,345View SEC Filing Icon  
8/4/2023Jeffrey V. PoultonCFOSell3,460$185.85$643,041.0015,873View SEC Filing Icon  
8/4/2023Pushkal GargCMOSell3,461$185.85$643,226.858,511View SEC Filing Icon  
8/4/2023Yvonne GreenstreetCEOSell4,057$185.85$753,993.4535,216View SEC Filing Icon  
4/27/2023Akshay VaishnawPresidentSell2,392$194.59$465,459.2817,890View SEC Filing Icon  
4/27/2023Jeffrey V. PoultonCFOSell977$194.59$190,114.4311,706View SEC Filing Icon  
4/27/2023Pushkal GargCMOSell1,839$194.59$357,851.016,800View SEC Filing Icon  
4/27/2023Tolga TangulerEVPSell1,476$194.59$287,214.841,801View SEC Filing Icon  
4/27/2023Yvonne GreenstreetCEOSell7,615$194.59$1,481,802.8530,332View SEC Filing Icon  
4/6/2023Indrani Lall FranchiniEVPSell3,500$210.00$735,000.00View SEC Filing Icon  
3/3/2023Pushkal GargCMOSell18,072$200.00$3,614,400.004,345View SEC Filing Icon  
2/2/2023Indrani Lall FranchiniEVPSell1,675$226.01$378,566.753,500View SEC Filing Icon  
See Full Table

SEC Filings (Institutional Ownership Changes) for Alnylam Pharmaceuticals (NASDAQ:ALNY)

92.97% of Alnylam Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ALNY by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Alnylam Pharmaceuticals Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
12/2/2025Allworth Financial LP1,290$0.59M0.0%+86.7%0.001%Search for SEC Filing on Google Icon
12/2/2025IFP Advisors Inc491$0.22M0.0%+145.5%0.000%Search for SEC Filing on Google Icon
12/2/2025Swiss Life Asset Management Ltd21,521$9.81M0.1%-9.5%0.016%Search for SEC Filing on Google Icon
12/1/2025Groupama Asset Managment4,032,082$18.61M0.1%+160.4%3.052%Search for SEC Filing on Google Icon
12/1/2025Polar Asset Management Partners Inc.4,104$1.87M0.0%-57.3%0.003%Search for SEC Filing on Google Icon
11/25/2025BlueCrest Capital Management Ltd1,231$0.56M0.0%N/A0.001%Search for SEC Filing on Google Icon
11/24/2025CIBC Private Wealth Group LLC214,213$97.68M0.2%-1.9%0.162%Search for SEC Filing on Google Icon
11/21/2025CIBC Bancorp USA Inc.4,675$2.13M0.0%N/A0.004%Search for SEC Filing on Google Icon
11/20/2025Ariadne Wealth Management LP703$0.32M0.2%+38.9%0.001%Search for SEC Filing on Google Icon
11/20/2025Wilmington Savings Fund Society FSB1,485$0.68M0.0%-11.9%0.001%Search for SEC Filing on Google Icon
11/20/2025First Affirmative Financial Network542$0.25M0.1%N/A0.000%Search for SEC Filing on Google Icon
11/20/2025Caerus Investment Advisors LLC1,672$0.76M0.3%N/A0.001%Search for SEC Filing on Google Icon
11/19/2025Captrust Financial Advisors7,669$3.50M0.0%+118.7%0.006%Search for SEC Filing on Google Icon
11/19/2025Coldstream Capital Management Inc.1,640$0.75M0.0%+2.4%0.001%Search for SEC Filing on Google Icon
11/19/2025Danske Bank A S57,407$26.18M0.1%N/A0.043%Search for SEC Filing on Google Icon
11/19/2025Caitong International Asset Management Co. Ltd63$29K0.0%N/A0.000%Search for SEC Filing on Google Icon
11/18/2025Silvant Capital Management LLC17,676$8.06M0.3%-8.6%0.013%Search for SEC Filing on Google Icon
11/18/2025Advisory Services Network LLC7,006$3.20M0.0%+9.2%0.005%Search for SEC Filing on Google Icon
11/17/2025Jacobs Levy Equity Management Inc.410,342$187.12M0.7%+2,221.7%0.311%Search for SEC Filing on Google Icon
11/17/2025Kestra Private Wealth Services LLC504$0.23M0.0%N/A0.000%Search for SEC Filing on Google Icon
11/17/2025NewEdge Advisors LLC1,524$0.70M0.0%+116.5%0.001%Search for SEC Filing on Google Icon
11/17/2025CANADA LIFE ASSURANCE Co93,092$41.63M0.1%+2.1%0.070%Search for SEC Filing on Google Icon
11/17/2025Woodline Partners LP91,791$41.86M0.2%-85.3%0.069%Search for SEC Filing on Google Icon
11/17/2025Dark Forest Capital Management LP11,598$5.29M0.2%N/A0.009%Search for SEC Filing on Google Icon
11/17/2025Proficio Capital Partners LLC488$0.22M0.0%-44.7%0.000%Search for SEC Filing on Google Icon
11/17/2025Zurich Insurance Group Ltd FI29,988$13.68M0.1%-55.8%0.023%Search for SEC Filing on Google Icon
11/17/2025United Capital Financial Advisors LLC2,145$0.98M0.0%+36.2%0.002%Search for SEC Filing on Google Icon
11/17/2025Utah Retirement Systems20,599$9.39M0.1%-1.8%0.016%Search for SEC Filing on Google Icon
11/17/2025Voleon Capital Management LP33,965$15.49M0.4%+2,404.8%0.026%Search for SEC Filing on Google Icon
11/17/2025Voloridge Investment Management LLC356,806$162.70M0.5%+4,532.6%0.270%Search for SEC Filing on Google Icon
11/17/2025Whitebox Advisors LLC2,100$0.96M0.0%N/A0.002%Search for SEC Filing on Google Icon
11/17/2025Verition Fund Management LLC17,033$7.77M0.0%+198.7%0.013%Search for SEC Filing on Google Icon
11/17/2025Tidal Investments LLC6,891$3.14M0.0%+23.6%0.005%Search for SEC Filing on Google Icon
11/17/2025Scientech Research LLC3,872$1.77M0.6%N/A0.003%Search for SEC Filing on Google Icon
11/17/2025SIH Partners LLLP1,020$0.47M0.0%N/A0.001%Search for SEC Filing on Google Icon
11/17/2025Sona Asset Management US LLC4,104$1.87M0.0%N/A0.003%Search for SEC Filing on Google Icon
11/17/2025Polar Capital Holdings Plc251,460$114.67M0.6%-90.8%0.190%Search for SEC Filing on Google Icon
11/17/2025Polymer Capital Management HK LTD28,900$13.18M1.8%+0.1%0.022%Search for SEC Filing on Google Icon
11/17/2025Polymer Capital Management US LLC808$0.37M0.0%N/A0.001%Search for SEC Filing on Google Icon
11/17/2025Quantessence Capital LLC15,874$7.24M2.3%N/A0.012%Search for SEC Filing on Google Icon
11/17/2025Qube Research & Technologies Ltd811,278$369.94M0.4%N/A0.614%Search for SEC Filing on Google Icon
11/17/2025Public Employees Retirement System of Ohio38,994$17.78M0.1%+0.6%0.030%Search for SEC Filing on Google Icon
11/17/2025Palo Alto Investors LP32,320$14.74M2.7%-57.2%0.024%Search for SEC Filing on Google Icon
11/17/2025Parkman Healthcare Partners LLC87,690$39.99M4.2%-5.0%0.066%Search for SEC Filing on Google Icon
11/17/2025Northwestern Mutual Wealth Management Co.567$0.26M0.0%+14.3%0.000%Search for SEC Filing on Google Icon
11/17/2025Northern Trust Corp833,151$379.92M0.0%+0.2%0.631%Search for SEC Filing on Google Icon
11/17/2025Mariner LLC26,332$12.01M0.0%+74.7%0.020%Search for SEC Filing on Google Icon
11/17/2025National Bank of Canada FI957$0.44M0.0%+6.0%0.001%Search for SEC Filing on Google Icon
11/17/2025Mercer Global Advisors Inc. ADV11,484$5.24M0.0%+348.1%0.009%Search for SEC Filing on Google Icon
11/17/2025MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.10,671$4.86M0.0%-7.7%0.008%Search for SEC Filing on Google Icon
11/17/2025Mirabella Financial Services LLP5,447$2.48M0.1%+83.4%0.004%Search for SEC Filing on Google Icon
11/17/2025Moore Capital Management LP4,104$1.87M0.0%N/A0.003%Search for SEC Filing on Google Icon
11/17/2025Knollwood Investment Advisory LLC4,059$1.85M0.2%-24.2%0.003%Search for SEC Filing on Google Icon
11/17/2025L2 Asset Management LLC611$0.28M0.0%N/A0.000%Search for SEC Filing on Google Icon
11/17/2025Linden Advisors LP14,364$6.55M0.0%N/A0.011%Search for SEC Filing on Google Icon
11/17/2025Laird Norton Wetherby Wealth Management LLC1,266$0.58M0.0%+3.3%0.001%Search for SEC Filing on Google Icon
11/17/2025Larson Financial Group LLC300$0.14M0.0%+35.1%0.000%Search for SEC Filing on Google Icon
11/17/2025Lido Advisors LLC658$0.30M0.0%N/A0.000%Search for SEC Filing on Google Icon
11/17/2025Lighthouse Investment Partners LLC3,500$1.60M0.0%N/A0.003%Search for SEC Filing on Google Icon
11/17/2025Integrated Wealth Concepts LLC4,636$2.11M0.0%+34.6%0.004%Search for SEC Filing on Google Icon
11/17/2025Jain Global LLC78,046$35.59M0.2%+366.5%0.059%Search for SEC Filing on Google Icon
11/17/2025Hilltop Holdings Inc.1,189$0.54M0.0%+29.8%0.001%Search for SEC Filing on Google Icon
11/17/2025Holocene Advisors LP13,086$5.97M0.0%-97.8%0.010%Search for SEC Filing on Google Icon
11/17/2025Humankind Investments LLC600$0.27M0.1%-33.0%0.000%Search for SEC Filing on Google Icon
11/17/2025Gotham Asset Management LLC28,135$12.83M0.1%+58.2%0.021%Search for SEC Filing on Google Icon
11/17/2025Fred Alger Management LLC1,986$0.91M0.0%N/A0.002%Search for SEC Filing on Google Icon
11/17/2025Focus Partners Wealth6,617$2.99M0.0%+110.1%0.005%Search for SEC Filing on Google Icon
11/17/2025EFG Asset Management Americas Corp.9,738$4.44M0.8%-16.2%0.007%Search for SEC Filing on Google Icon
11/17/2025BlueCrest Capital Management Ltd1,231$0.56M0.0%N/A0.001%Search for SEC Filing on Google Icon
11/17/2025Brevan Howard Capital Management LP6,170$2.81M0.0%N/A0.005%Search for SEC Filing on Google Icon
11/17/2025Capula Management Ltd6,888$3.14M0.0%N/A0.005%Search for SEC Filing on Google Icon
11/17/2025Casdin Capital LLC55,000$25.08M2.1%-32.5%0.042%Search for SEC Filing on Google Icon
11/17/2025Bamco Inc. NY3,500$1.60M0.0%N/A0.003%Search for SEC Filing on Google Icon
11/17/2025California Public Employees Retirement System229,641$104.72M0.1%+8.5%0.174%Search for SEC Filing on Google Icon
11/17/2025Bank of Nova Scotia5,944$2.71M0.0%+121.9%0.004%Search for SEC Filing on Google Icon
11/17/2025Brandywine Managers LLC3,718$1.70M1.6%-11.9%0.003%Search for SEC Filing on Google Icon
11/17/2025Anchor Investment Management LLC2,249$1.03M0.1%+1,024.5%0.002%Search for SEC Filing on Google Icon
11/17/2025Aquatic Capital Management LLC84,059$38.33M0.7%N/A0.064%Search for SEC Filing on Google Icon
11/17/2025Alliancebernstein L.P.43,776$19.96M0.0%-34.8%0.033%Search for SEC Filing on Google Icon
11/17/2025Ameriprise Financial Inc.225,879$103M0.0%-95.2%0.171%Search for SEC Filing on Google Icon
11/14/2025Shaolin Capital Management LLC4,104$1.87M0.1%N/A0.003%Search for SEC Filing on Google Icon
11/14/2025Schonfeld Strategic Advisors LLC9,709$4.43M0.0%-83.5%0.007%Search for SEC Filing on Google Icon
11/14/2025Creative Planning22,862$10.43M0.0%+46.7%0.017%Search for SEC Filing on Google Icon
11/14/2025Polar Asset Management Partners Inc.4,104$1.87M0.0%-57.3%0.003%Search for SEC Filing on Google Icon
11/14/2025SummitTX Capital L.P.7,525$3.43M0.1%+56.8%0.006%Search for SEC Filing on Google Icon
11/14/2025AQR Capital Management LLC744,008$336.01M0.2%+295.2%0.563%Search for SEC Filing on Google Icon
11/14/2025Zacks Investment Management11,904$5.43M0.0%-0.2%0.009%Search for SEC Filing on Google Icon
11/14/2025Credit Agricole S A12,367$5.64M0.0%N/A0.009%Search for SEC Filing on Google Icon
11/14/2025Raymond James Financial Inc.377,294$172.05M0.1%+39.0%0.286%Search for SEC Filing on Google Icon
11/14/2025Bellevue Group AG446,524$203.62M4.2%-34.0%0.338%Search for SEC Filing on Google Icon
11/14/2025Virtu Financial LLC11,656$5.32M0.3%N/A0.009%Search for SEC Filing on Google Icon
11/14/2025Amundi384,272$173.69M0.1%-89.3%0.291%Search for SEC Filing on Google Icon
11/14/2025Caisse de depot et placement du Quebec17,826$8.13M0.0%-11.1%0.013%Search for SEC Filing on Google Icon
11/14/2025Freestone Grove Partners LP1,412$0.64M0.0%N/A0.001%Search for SEC Filing on Google Icon
11/14/2025Deerfield Management Company L.P.67,935$30.98M0.5%-99.9%0.051%Search for SEC Filing on Google Icon
11/14/2025Qtron Investments LLC1,471$0.67M0.1%N/A0.001%Search for SEC Filing on Google Icon
11/14/2025Man Group plc71,673$32.68M0.1%-97.5%0.054%Search for SEC Filing on Google Icon
11/14/2025Orbimed Advisors LLC301,600$137.53M3.4%-11.8%0.228%Search for SEC Filing on Google Icon
11/14/2025California State Teachers Retirement System203,778$92.92M0.1%+2.2%0.154%Search for SEC Filing on Google Icon
11/14/2025Daiwa Securities Group Inc.15,496$7.07M0.0%+19.7%0.012%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Alnylam Pharmaceuticals logo
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. Its marketed products include ONPATTRO (patisiran) for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; AMVUTTRA for the treatment of hATTR amyloidosis with polyneuropathy in adults; GIVLAARI for the treatment of adults with acute hepatic porphyria; and OXLUMO for the treatment of primary hyperoxaluria type 1. In addition, the company develops patisiran for the treatment of transthyretin amyloidosis, or ATTR amyloidosis, with cardiomyopathy; cemdisiran to treat complement-mediated diseases; Belcesiran for the treatment of alpha-1 liver disease; Elebsiran to treat chronic HBV infection; Zilebesiran to treat hypertension; ALN-APP to treat Alzheimer's disease and cerebral amyloid angiopathy; and ALN-HSD to treat NASH. Further, it offers Fitusiran for the treatment of hemophilia, Inclisiran to treat hypercholesterolemia, lumasiran for the treatment of advanced PH1, and vutrisiran for the treatment of ATTR amyloidosis, which is in phase 3 clinical trial. Alnylam Pharmaceuticals, Inc. has strategic collaborations with Regeneron Pharmaceuticals, Inc. to discover, develop, and commercialize RNAi therapeutics for a range of diseases by addressing therapeutic targets expressed in the eye and CNS; and Roche to develop pharmaceutical products containing zilebesiran. It also has license and collaboration agreements with Novartis AG; Vir Biotechnology, Inc.; Dicerna Pharmaceuticals, Inc.; Ionis Pharmaceuticals, Inc.; and PeptiDream, Inc. The company was founded in 2002 and is headquartered in Cambridge, Massachusetts.
Read More on Alnylam Pharmaceuticals

Today's Range

Now: $465.34
Low: $463.03
High: $477.06

50 Day Range

MA: $456.55
Low: $423.47
High: $491.22

52 Week Range

Now: $465.34
Low: $205.87
High: $495.55

Volume

983,973 shs

Average Volume

907,941 shs

Market Capitalization

$61.48 billion

P/E Ratio

1,938.92

Dividend Yield

N/A

Beta

0.3

Who are the company insiders with the largest holdings of Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals' top insider investors include:
  1. Yvonne Greenstreet (CEO)
  2. Jeffrey V Poulton (EVP)
  3. Jeffrey V Poulton (CFO)
  4. Tolga Tanguler (EVP)
  5. Kevin Joseph Fitzgerald (EVP)
  6. Pushkal Garg (EVP)
  7. Pushkal Garg (CMO)
  8. Michael W Bonney (Director)
  9. Amy W Schulman (Director)
  10. Dennis A Ausiello (Director)
  11. Colleen F Reitan (Director)
  12. David E I Pyott (Director)
  13. Phillip A Sharp (Director)
Learn More about top insider investors at Alnylam Pharmaceuticals.

Who are the major institutional investors of Alnylam Pharmaceuticals?

Alnylam Pharmaceuticals' top institutional shareholders include:
  1. Capital World Investors — 12.44%
  2. Vanguard Group Inc. — 10.27%
  3. Capital Research Global Investors — 5.47%
  4. Groupama Asset Managment — 3.05%
  5. Baillie Gifford & Co. — 2.13%
  6. Dodge & Cox — 1.76%
Learn More about top institutional investors of Alnylam Pharmaceuticals stock.

Which major investors are selling Alnylam Pharmaceuticals stock?

In the last quarter, ALNY stock was sold by these institutional investors:
  1. Deerfield Management Company L.P.
  2. Invesco Ltd.
  3. Ameriprise Financial Inc.
  4. Amundi
  5. Regeneron Pharmaceuticals Inc.
  6. Man Group plc
  7. Polar Capital Holdings Plc
  8. Barclays PLC
During the last year, company insiders that have sold Alnylam Pharmaceuticals company stock include:
  1. Yvonne Greenstreet (CEO)
  2. Jeffrey V Poulton (EVP)
  3. Jeffrey V Poulton (CFO)
  4. Tolga Tanguler (EVP)
  5. Kevin Joseph Fitzgerald (EVP)
  6. Pushkal Garg (EVP)
  7. Pushkal Garg (CMO)
  8. Michael W Bonney (Director)
  9. Amy W Schulman (Director)
  10. Dennis A Ausiello (Director)
  11. Colleen F Reitan (Director)
Learn More investors selling Alnylam Pharmaceuticals stock.

Which major investors are buying Alnylam Pharmaceuticals stock?

In the previous quarter, ALNY stock was acquired by institutional investors including:
  1. Groupama Asset Managment
  2. Arrowstreet Capital Limited Partnership
  3. Qube Research & Technologies Ltd
  4. AQR Capital Management LLC
  5. Jacobs Levy Equity Management Inc.
  6. Massachusetts Financial Services Co. MA
  7. Voloridge Investment Management LLC
  8. Susquehanna Advisors Group Inc.